Coverage of Conditions and Treatments (Coverage Decisions)

Use this lookup tool to determine coverage decisions, or if prior authorization is needed for the treatment or condition. Note: For Self-insured employer claims, you must contact the employer or their claims administrator.

List also available in PDF format.

Archived Coverage Decisions.

See Treatment Guidelines and Resources for additional information.

The NeuMed Brevio® nerve conduction testing system is a handheld device intended for use in evaluating nerve function.

Coverage decision

The Brevio® Nerve Conduction Testing System is not covered at this time. L&I reviewed the scientific literature and determined there is not sufficient evidence of efficacy for this diagnostic tool. Brevio® is considered investigational and experimental.

This coverage decision applies to all State Fund and self-insured claims in all locations.

Background information

The NeuMed Brevio is a handheld device intended for use in evaluating nerve function. Similar to conventional nerve conduction study devices, the Brevio® assesses function via surface electrodes. This evidence does not support the accuracy or reliability of Nervepace for use as a diagnostic or screening tool for any condition(s) and specifically for carpal tunnel syndrome.

Billing information

Nerve conduction tests performed with Brevio® do not have unique billing codes at this time. The manufacturer of Brevio® recommends use of CPT codes:

• 95900,
• 95903,
• 95904.

These codes apply to billing for motor nerve testing, motor nerve testing with F-waves and sensory nerve testing.

Note: These codes are approved only for nerve conduction studies performed with traditional nerve conduction testing systems.

In accordance with WAC 296-20-03002, L&I will not pay for treatment which is considered experimental in nature. L&I may recoup payments plus interest for nerve conduction tests paid inappropriately.

Brevio® Assessment